Novel glitazones: glucose uptake and cytotoxic activities, and structure-activity relationships

被引:8
作者
Kumar, B. R. Prashantha [1 ]
Kumar, S. Santhosh [1 ]
Viral, Patel [1 ]
Wadhwani, Ashish [1 ]
Vadivelan, R. [1 ]
Kumar, M. N. Satish [1 ]
Elango, K. [1 ]
Nanjan, M. J. [1 ]
机构
[1] JSS Coll Pharm, Ootacamund 643001, India
关键词
Diabetes; glitazones; Glucose uptake; PPAR-gamma; thiazolidinediones; Cytotoxic activity; ANTIHYPERGLYCEMIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; ANTIDIABETIC AGENTS; HYPOGLYCEMIC AGENTS; INSULIN-RESISTANCE; SERUM GLUCOSE; DERIVATIVES; CANCER; THIAZOLIDINEDIONES; CIGLITAZONE;
D O I
10.1007/s00044-011-9792-0
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
In this article, two series of novel glitazones are reported for their synthesis, in vitro glucose uptake activity by the rat hemi-diaphragm, and in vitro cytotoxic activity against human carcinoma HEp-2 (epidermoid carcinoma of the larynx) and A549 (human lung cancer cell line) cells. Some of the compounds exhibit good glucose uptake and cytotoxic activities. Compound 5 with 2,4-dichlorophenol moiety connected to TZD via the two carbon linker has exhibited good glucose uptake activity. One of the compounds exhibits both cytotoxic and glucose uptake activities (compound 4). Illustrations about their synthesis, and in vitro glucose uptake and cytotoxic activities are described along with their structure-activity relationships. Designed, synthesized some novel glitazones and evaluated them for their glucose uptake and cytotoxic activities.
引用
收藏
页码:2689 / 2701
页数:13
相关论文
共 29 条
[1]   Novel inhibitors of an emerging target in Mycobacterium tuberculosis;: Substituted thiazolidinones as inhibitors of dTDP-rhamnose synthesis [J].
Babaoglu, K ;
Page, MA ;
Jones, VC ;
McNeil, MR ;
Dong, CJ ;
Naismith, JH ;
Lee, RE .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (19) :3227-3230
[2]   Synthesis and preliminary evaluation of some pyrazine containing thiazolines and thiazolidinones as antimicrobial agents [J].
Bonde, CG ;
Gaikwad, NJ .
BIOORGANIC & MEDICINAL CHEMISTRY, 2004, 12 (09) :2151-2161
[3]  
Carlisle BA, 2007, HDB APPL THERAPEUTIC, P491
[4]   CIGLITAZONE, A NEW HYPOGLYCEMIC AGENT .1. STUDIES IN OB/OB AND DB/DB MICE, DIABETIC CHINESE HAMSTERS, AND NORMAL AND STREPTOZOTOCIN-DIABETIC RATS [J].
CHANG, AY ;
WYSE, BM ;
GILCHRIST, BJ ;
PETERSON, T ;
DIANI, AR .
DIABETES, 1983, 32 (09) :830-838
[5]  
Chattopadhyay R R, 1992, Indian J Physiol Pharmacol, V36, P137
[6]   BENZYLOXAZOLIDINE-2,4-DIONES AS POTENT HYPOGLYCEMIC AGENTS [J].
DOW, RL ;
BECHLE, BM ;
CHOU, TT ;
CLARK, DA ;
HULIN, B ;
STEVENSON, RW .
JOURNAL OF MEDICINAL CHEMISTRY, 1991, 34 (05) :1538-1544
[7]   Clinical efficacy of new thiazolidinediones and glinides in the treatment of type 2 diabetes mellitus [J].
Füchtenbusch, M ;
Standl, E ;
Schatz, H .
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2000, 108 (03) :151-163
[8]   REDUCTION OF INSULIN RESISTANCE IN OBESE AND OR DIABETIC ANIMALS BY 5-[4-(1-METHYLCYCLOHEXYLMETHOXY)BENZYL]-THIAZOLIDINE-2,4-DIONE (ADD-3878, U-63,287, CIGLITAZONE), A NEW ANTI-DIABETIC AGENT [J].
FUJITA, T ;
SUGIYAMA, Y ;
TAKETOMI, S ;
SOHDA, T ;
KAWAMATSU, Y ;
IWATSUKA, H ;
SUZUOKI, Z .
DIABETES, 1983, 32 (09) :804-810
[9]  
Ghosh R., 2004, Indian Journal of Pharmacology, V36, P222
[10]   Modulation of glucose transporters in rat diaphragm by sodium tungstate [J].
Girón, MD ;
Caballero, JJ ;
Vargas, AM ;
Suárez, MD ;
Guinovart, J ;
Salto, R .
FEBS LETTERS, 2003, 542 (1-3) :84-88